RNA interference mediating small RNA molecules
AssigneeMax-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
InventorsThomas Tuschl, Sayda Mahgoub Elbashir, Winfried Lendeckel
Life of this patent
Estimating the term…
Loading patent…
AssigneeMax-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
InventorsThomas Tuschl, Sayda Mahgoub Elbashir, Winfried Lendeckel
Estimating the term…
Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19–23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3′ ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.
A method of preparing a double-stranded RNA molecule, wherein each RNA strand has a length from 19–25 nucleotides, wherein said RNA molecule is capable of target-specific nucleic acid modifications and wherein at least one strand has a 3′-overhang of 1–5 nucleotides, comprising
A method of preparing a double-stranded RNA molecule, wherein each strand has a length of from 19–25 nucleotides, wherein said RNA molecule is capable of mediating the cleavage of a target mRNA in a mammal and at least one strand has a 3′ overhang of 1–3 nucleotides, comprising the steps of:
A method of preparing a double-stranded RNA molecule, wherein each RNA strand has a length from 19–23 nucleotides, wherein said RNA molecule is capable of target-specific nucleic acid modifications and wherein at least one strand has a 3′-overhang of 1–5 nucleotides, comprising
A method of preparing a double-stranded RNA molecule, wherein each strand has a length of from 19–23 nucleotides, wherein said RNA molecule is capable of mediating the cleavage of a target mRNA in a mammal and at least one strand has a 3 overhang of 1–3 nucleotides, comprising the steps of:
A method of preparing a double-stranded RNA molecule, wherein each RNA strand has a length from 19–25 nucleotides, wherein said RNA molecule is capable of target-specific nucleic acid modifications and wherein at least one strand has a 3′-overhang of 1–5 nucleotides, comprising
A method of preparing a double-stranded RNA molecule, wherein each strand has a length of from 19–25 nucleotides, wherein said RNA molecule is capable of mediating the cleavage of a target mRNA in a mammal and at least one strand has a 3′ overhang of 1–3 nucleotides, comprising the steps of:
A method of preparing a double-stranded RNA molecule, wherein each RNA strand has a length from 19–23 nucleotides, wherein said RNA molecule is capable of target-specific nucleic acid modifications and wherein at least one strand has a 3′-overhang of 1–5 nucleotides, comprising
A method of preparing a double-stranded RNA molecule, wherein each strand has a length of from 19–23 nucleotides, wherein said RNA molecule is capable of mediating the cleavage of a target mRNA in a mammal and at least one strand has a 3′ overhang of 1–3 nucleotides, comprising the steps of:
Dependencies are inferred from the claim text.